Stocks and Investing Stocks and Investing
Mon, March 13, 2017

Terence Flynn Upgraded (BPMC) to Strong Buy on, Mar 13th, 2017


Published on 2024-10-25 20:28:16 - WOPRAI, Terence Flynn
  Print publication without navigation


Terence Flynn of Goldman Sachs, Upgraded "Blueprint Medicines Corporation" (BPMC) to Strong Buy on, Mar 13th, 2017.

Terence has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Terence's Rating of Hold.



This is the rating of the analyst that currently disagrees with Terence


  • Andrew Berens of "Morgan Stanley" Initiated at Buy on, Wednesday, February 15th, 2017

Contributing Sources